Pharmacy Board recalls three drugs over safety concerns, including paracetamol batches
Pharmacy Board recalls three drugs over safety concerns, including paracetamol batches
The Pharmacy and Poisons Board (PPB) has raised safety concerns over specific batches of widely used pharmaceutical drugs.
In an alert issued on Thursday, April 24, the PPB mandated the recall of S-Prazo (Esomeprazole 40mg) Batch Number SPZ404, manufactured by Medico Remedies Pharmaceutical India Limited.
According to the agency, the move follows the discovery of a Levofloxacin 500mg tablet in a pack of Esomeprazole 40mg capsules.
“In execution of the foregoing mandate, the Board draws public attention to the detection of a product mix-up involving S-Prazo (Esomeprazole 40mg) Batch No. SPZ404 wherein it was reported and confirmed that a strip of Levofloxacin 500mg tablet was found in a pack of Esomeprazole 40mg capsules,” the notice read.
The board has instructed all pharmaceutical outlets and the general public to stay away from the outlined product batch.
“In view of the above, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately cease further distribution, sale, issuing, or use of the outlined product batch and return the same to their nearest healthcare facility or respective suppliers,” the notice added.
Polished speeches, zero execution: Vietnamese Energy Mogul rebukes President Ruto
JSC announces internship opportunities for degree and diploma holders; How to apply
SHA declined to enroll over 360,000 teachers for health coverage – TSC CEO reveals
Gachagua hosts Meru delegation led by Mithika Linturi at his Wamunyoro residence
China sends Boeing planes back to US over tariffs
In a separate alert, the PPB warned of falsified Augmentin medicines detected in the Kenyan market, affecting the Augmentin 1g Batch SGS2 and Augmentin 625mg Batches: 8X3K and EU7C.
Similarly, the board has directed all concerned to halt any usage or sale of the affected batches and return them immediately.
“In view of the above, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately cease further distribution, sale, issuing, or use of the outlined product batch and return the same to their nearest healthcare facility or respective suppliers.
“The board encourages the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board,” the statement read.
Uhuru Kenyatta meets Museveni in Uganda (Details)
Vatican releases details of Pope Francis’s marble tomb
Lobby group demands fresh IEBC interviews, accuses panel of shortlisting Ruto loyalists
Education PS Julius Bitok announces date for selection of senior school
Kenya wins big as Ruto signs 24 MoUs with China
7 possible ways of rigging elections in Kenya; Former IEBC boss
Follow us
